Chaitanya Sudrik

Chaitanya Sudrik

Auto-generated profile, based on publicly available information

Chaitanya Sudrik

Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180 (USA)

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2019 in Toxicology Mechanisms and Methods
Verified
Journal Article
Open access
Ajay Vikram SinghAjay Vikram Singh
Ajay Vikram Singh
PLPeter Laux
Peter Laux
ALAndreas Luch
Andreas Luch
CSChaitanya Sudrik
Chaitanya Sudrik
SWStefan Wiehr
Stefan Wiehr
MSMetin Sitti
Metin Sitti
Nanotoxicology and nanosafety has been a topic of intensive research for about more than 20 years. Nearly 10,000 research papers have been published on the topic, yet there exists a gap in terms of understanding and ways to harmonize nanorisk assessment. In this review, we revisit critically ignored parameters of nanoscale materials (e.g. band gap factor, phase instability and silver leaching problem, defect and instability plasmonic vs. inorganic particles) versus their biological counterparts (cell batch-to-batch heterogeneity, biological barrier model design, cellular functional characteristics) which yield variability and nonuniformity in results. We also emphasize system biology approaches to integrate the high throughput screening methods coupled with in-vivo and in-silico modelling to ensure quality in nanosafety research. We emphasize and highlight the recommendation regarding bridging the mechanistic gaps in fundamental research and predictive biological response in nanotoxicology. The research community has to develop visions to predict the unforeseen problems that do not exist yet in context with nanotoxicity and public health hazards due to the burgeoning use of nanomaterial in consumer’s product.

31 July 2017 in mAbs
Verified
Journal Article
Closed access
CSChaitanya Sudrik
Chaitanya Sudrik
TCTheresa Cloutier
Theresa Cloutier
PPPhuong Pham
Phuong Pham
HSHardeep S. Samra
Hardeep S. Samra
BTBernhardt L. Trout
Bernhardt L. Trout
Preferential interactions of weakly interacting formulation excipients govern their effect on the equilibrium and kinetics of several reactions of protein molecules in solution. Using vapor pressure osmometry, we characterized the preferential interactions of commonly used excipients trehalose, L-arginine.HCl and NaCl with three therapeutically-relevant, IgG1 monoclonal antibodies that have similar size and shape, but differ in their surface hydrophobicity and net charge. We further characterized the effect of these excipients on the reversible self-association, aggregation and viscosity behavior of these antibody molecules. We report that trehalose, L-arginine.HCl and NaCl are all excluded from the surface of the three IgG1 monoclonal antibodies, and that the exclusion behavior is linearly related to the excipient molality in the case of trehalose and NaCl, whereas a non-linear behavior is observed for L-arginine.HCl. Interestingly, we find that the magnitude of trehalose exclusion depends upon the nature of the protein surface. Such behavior is not observed in case of NaCl and L-arginine.HCl as they are excluded to the same extent from the surface of all three antibody molecules tested in this study. Analysis of data presented in this study provides further insight into the mechanisms governing excipient-mediated stabilization of mAb formulations.

26 March 2014 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
JCJicong Cao
Jicong Cao
MAManish Arha
Manish Arha
CSChaitanya Sudrik
Chaitanya Sudrik
DSDavid Schaffer
David Schaffer
RKRavi S Kane
Ravi S Kane

6 April 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JCJicong Cao
Jicong Cao
MAManish Arha
Manish Arha
CSChaitanya Sudrik
Chaitanya Sudrik
AMAbhirup Mukherjee
Abhirup Mukherjee
XWXia Wu
Xia Wu
RKRavi S Kane
Ravi S Kane
We describe a simple strategy to control mRNA translation in both prokaryotic and eukaryotic cells which relies on a unique protein–RNA interaction. Specifically, we used the Pumilio/FBF (PUF) protein to repress translation by binding in between the ribosome binding site (RBS) and the start codon (in Escherichia coli), or by binding to the 5′ untranslated region of target mRNAs (in mammalian cells). The design principle is straightforward, the extent of translational repression can be tuned and the regulator is genetically encoded, enabling the construction of artificial signal cascades. We demonstrate that this approach can also be used to regulate polycistronic mRNAs; such regulation has rarely been achieved in previous reports. Since the regulator used in this study is a modular RNA-binding protein, which can be engineered to target different 8-nucleotide RNA sequences, our strategy could be used in the future to target endogenous mRNAs for regulating metabolic flows and signaling pathways in both prokaryotic and eukaryotic cells.

14 September 2018 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
TCTheresa Cloutier
Theresa Cloutier
CSChaitanya Sudrik
Chaitanya Sudrik
HSHasige A. Sathish
Hasige A. Sathish
BTBernhardt L. Trout
Bernhardt L. Trout

1 January 2013 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JCJicong Cao
Jicong Cao
MAManish Arha
Manish Arha
CSChaitanya Sudrik
Chaitanya Sudrik
LBLukasz J. Bugaj
Lukasz J. Bugaj
DSDavid V. Schaffer
David V. Schaffer
RKRavi S. Kane
Ravi S. Kane
A genetically encoded optogenetic system was constructed that activates mRNA translation in mammalian cells in response to light. Blue light induces the reconstitution of an RNA binding domain and a translation initiation domain, thereby activating target mRNA translation downstream of the binding sites.